Our physicians are also deeply involved in investigating promising new therapies in the clinical setting. In 2012, we are expanding our clinical trials program, enabling more patients to access innovative therapies. The survival rate for breast cancer has increased dramatically over the last two decades, thanks to our and others’ tenacity in systematically testing new therapies. Through our strong and growing clinical trials program, we are helping define the treatments that will improve outcomes for all cancers in the decades ahead.


A Patient-centered Model of Care


Because the journey through diagnosis and treatment to survivorship can be challenging, many patients today experience cancer as a relay race through a maze of caregivers. Cancer is a complicated disease, and most patients require several different kinds of treatment. At Froedtert & The Medical College of Wisconsin, we offer a highly coordinated approach in a state-of-the-art, compassionate environment.


Our innovative hub model puts the patient at the center of care. Each patient’s team includes surgical oncologists, hematologist/oncologists, radiation oncologists, radiologists and other significant clinical experts who specialize in their specific cancer. All of these physicians see patients in the Clinical Cancer Center, so patients don’t have to visit multiple locations to receive care from different specialists. The single location also makes it easier for physicians to work together and ensure that care progresses smoothly. The hub model not only provides the best possible experience for patients, it ensures that all patients receive optimal treatment.


At the Clinical Cancer Center, patients are treated by physicians who are specialists in their particular disease. For instance, our gynecologic oncologists provide the most current treatment strategies for ovarian cancer. Urologic, medical and radiation oncologists in our Prostate and Urologic Cancer Program offer the latest therapies for prostate, bladder and kidney disease. Similarly, a multidisciplinary team specializing in breast cancer offers personalized therapies for each woman’s type of breast cancer. This is important, because every disease has its own, subtle nuances.


continued


Special Report 2012


Mary Horowitz, MD, MS


3


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24